Innovative Technology MEGIN leads in Magnetoencephalography (MEG) technology, offering advanced brain imaging solutions that are essential for neuroscience research and clinical diagnostics, presenting opportunities to equip leading research institutions and hospitals.

Global Presence With operations across Finland, the UK, USA, and Japan, MEGIN provides a broad international footprint, enabling targeted sales efforts in diverse healthcare markets and facilitating expansion into emerging regions.

Research Collaborations The recent partnership with Findsurgicalsciences and FIND Neuro highlights ongoing collaborations in brain network mapping, presenting opportunities to develop joint offerings or expand current customer relationships involving neurological treatment centers.

Growing Market With annual revenues between $10M and $50M and a competitive landscape with similar companies like Magstim and Neuroelectrics, MEGIN is positioned in a growing niche focused on brain health, ideal for targeted marketing and lead generation.

Customer-Centric Approach MEGIN’s mission emphasizes customer focus and translating research into accessible clinical solutions, signaling potential sales avenues through customized product demonstrations and tailored solutions for hospitals and research labs seeking advanced brain imaging modalities.